Peritoneal dosing recommendation gabapentin

Size: px
Start display at page:

Download "Peritoneal dosing recommendation gabapentin"

Transcription

1 Peritoneal dosing recommendation gabapentin Search Latest news from AFSPA on Federal Employees Health Information for Health Care Professionals : Cannabis (marihuana, marijuana) and the cannabinoids [Health Canada, 2013]. 8 posts published by Tony Abraham Thomas during April Atripla 600 mg/200 mg/ 245 mg film coated tablets - Summary of Product Characteristics (SmPC) by Gilead Sciences Ltd. Can be considered as an alternative to the Mepilex products above or if a patient reports sensitivity issuses following previous use of Mepilex products The prevalence of end-stage renal disease continues to increase, and dialysis is offered to older and more medically complex patients. Pain is problematic. PROSPECT Recommendations. A recommendation of anaesthetic choice based on postoperative analgesic effect cannot be made for abdominal hysterectomy, because there. Hembree and colleagues (2009) formulated practice guidelines for endocrine treatment of transsexual persons. This evidence-based guideline was developed using the. An endstage renal disease patient on long-term peritoneal dialysis was admitted with dizziness, fatigue, hypoglycemia, and hypotension. except gabapentin, the dose of which was recently doubled 1 month before admission. Insulin and C- peptide levels.. Current dose recommendations for gabapentin in patients on. Contrib Nephrol. 2012;177:30-7. doi: / Epub 2012 May 8. Appropriate drug dosing in patients receiving peritoneal dialysis. Hirata S(1), Kadowaki D. Author information: (1)Division of Clinical Pharmacology, Center for Clinical Pharmaceutical Sciences, Faculty of Pharmaceutical Sciences, Kumamoto. Advances in Peritoneal Dialysis, Vol. 25, Drug-Induced. Encephalopathy Secondary to Non Renal lowing exposure to usual doses of gabapentin and acyclovir are presented here. Their cases portray the ± 26 ml/min (6). Even the reduced daily dose of. 300 mg gabapentin recommended for ESRD patients. Feb 1, A study in the USA found up to one-third of haemodialysis patients are prescribed a drug at a dose that differs from the recommended dose and adverse and dialysate (haemodialysis), or by instilling dialysate into the peritoneal cavity and using the peritoneum itself as a membrane (peritoneal dialysis). Drug removal by peritoneal dialysis (PD) or continuous renal replacement therapy (CVVHD, CAVHD, etc.) is not equivalent to... permeability. Consult unit pharmacist for dosing adjustment recommendations. Gabapentin (PO)D**. Titrate to clinical response, use caution in renal failure. > mg three times daily. Jul 25, Give supplemental dose of mg after each dialysis. Dosage given should be proportional to maintenance dose. Patients receiving at least 300mg/day can be given the higher supplemental dose of 350mg after each dialysis. Other patients should receive a dosage at the lower end of this range. Marquette General Pharmacy DLP. Renal Dosing Protocol. Drug. Usual Dose. CrCl Adjusted. (ml/min) Dose. Hemodialysis/. Peritoneal Dialysis/ Comments.. Not recommended. Daptomycin (IV). 4-10mg/kg daily. <30. Usual dose q48h. HD Dose as for CrCl. <30ml/min. Give after HD on dialysis days. Enoxaparin (SQ). NEUROPATHIC PAIN. Amitriptyline starting dose needs no adjustment unless sedation is undesirable. Must be titrated carefully. If amitriptyline is

2 inappropriate, gabapentin and pregabalin require significant dose adjustments. Dexamethasone does not require dose adjustment, but may be complicated by fluid retention. The recommended maintenance dose of NEURONTIN in patients 3 to 4 years of age is. 40 mg/kg/day, hemodialysis is recommended, as follows (see dosing recommendations above for effective doses in each... In a published study, gabapentin (400 mg/kg/day) was administered by intraperitoneal injection to neonatal. Does adherence to the guideline recommendation for active treatments improve the quality of. Gabapentin in the. Opioid Dosing Guideline for Chronic. Hembree and colleagues (2009) formulated practice guidelines for endocrine treatment of transsexual persons. This evidence-based guideline was developed using the. Information for Health Care Professionals: Cannabis (marihuana, marijuana) and the cannabinoids [Health Canada, 2013]. The prevalence of end-stage renal disease continues to increase, and dialysis is offered to older and more medically complex patients. Pain is problematic in up to. Atripla 600 mg/200 mg/245 mg film coated tablets - Summary of Product Characteristics (SmPC) by Gilead Sciences Ltd. PROSPECT Recommendations. A recommendation of anaesthetic choice based on postoperative analgesic effect cannot be made for abdominal hysterectomy, because there is. 8 posts published by Tony Abraham Thomas during April Can be considered as an alternative to the Mepilex products above or if a patient reports sensitivity issuses following previous use of Mepilex products. Gabapentin in the treatment of. Opioid Dosing Guideline for Chronic Non-Cancer. While all appear to support the recommendation that COX-2 inhibitors should. Latest news from AFSPA on Federal Employees Health. 8 posts published by Tony Abraham Thomas during April PROSPECT Recommendations. A recommendation of anaesthetic choice based on postoperative analgesic effect cannot be made for abdominal hysterectomy, because there. Hembree and colleagues (2009) formulated practice guidelines for endocrine treatment of transsexual persons. This evidence-based guideline was developed using the. Latest news from AFSPA on Federal Employees Health. Atripla 600 mg/200 mg/ 245 mg film coated tablets - Summary of Product Characteristics (SmPC) by Gilead Sciences Ltd. Can be considered as an alternative to the Mepilex products above or if a patient reports sensitivity issuses following previous use of Mepilex products The prevalence of end-stage renal disease continues to increase, and dialysis is offered to older and more medically complex patients. Pain is problematic Information for Health Care Professionals : Cannabis (marihuana, marijuana) and the cannabinoids [Health Canada, 2013]. Feb 1, A study in the USA found up to one-third of haemodialysis patients are prescribed a drug at a dose that differs from the recommended dose and adverse and dialysate (haemodialysis), or by instilling dialysate into the peritoneal cavity and using the peritoneum itself as a membrane (peritoneal dialysis). The recommended maintenance dose of NEURONTIN in patients 3 to 4 years of age is. 40 mg/kg/day, hemodialysis is recommended, as follows (see dosing recommendations above for effective doses in each... In a published study, gabapentin (400 mg/kg/day) was administered by intraperitoneal injection to neonatal. An end-stage renal disease patient on long-term peritoneal dialysis was admitted with dizziness, fatigue, hypoglycemia, and hypotension. except gabapentin, the dose of which was recently doubled 1 month before admission. Insulin and C- peptide levels.. Current dose recommendations for gabapentin in patients on. Contrib Nephrol. 2012;177:30-7. doi: / Epub 2012 May 8. Appropriate drug dosing in patients receiving peritoneal dialysis. Hirata S(1), Kadowaki D. Author information: (1)Division of Clinical Pharmacology, Center for Clinical Pharmaceutical Sciences, Faculty of Pharmaceutical Sciences, Kumamoto.

3 NEUROPATHIC PAIN. Amitriptyline starting dose needs no adjustment unless sedation is undesirable. Must be titrated carefully. If amitriptyline is inappropriate, gabapentin and pregabalin require significant dose adjustments. Dexamethasone does not require dose adjustment, but may be complicated by fluid retention. Drug removal by peritoneal dialysis (PD) or continuous renal replacement therapy (CVVHD, CAVHD, etc.) is not equivalent to... permeability. Consult unit pharmacist for dosing adjustment recommendations. Gabapentin (PO)D**. Titrate to clinical response, use caution in renal failure. > mg three times daily. Jul 25, Give supplemental dose of mg after each dialysis. Dosage given should be proportional to maintenance dose. Patients receiving at least 300mg/day can be given the higher supplemental dose of 350mg after each dialysis. Other patients should receive a dosage at the lower end of this range. Marquette General Pharmacy DLP. Renal Dosing Protocol. Drug. Usual Dose. CrCl Adjusted. (ml/min) Dose. Hemodialysis/. Peritoneal Dialysis/ Comments.. Not recommended. Daptomycin (IV). 4-10mg/kg daily. <30. Usual dose q48h. HD Dose as for CrCl. <30ml/min. Give after HD on dialysis days. Enoxaparin (SQ). Advances in Peritoneal Dialysis, Vol. 25, Drug- Induced. Encephalopathy Secondary to Non Renal lowing exposure to usual doses of gabapentin and acyclovir are presented here. Their cases portray the ± 26 ml/min (6). Even the reduced daily dose of. 300 mg gabapentin recommended for ESRD patients. Can be considered as an alternative to the Mepilex products above or if a patient reports sensitivity issuses following previous use of Mepilex products. The prevalence of endstage renal disease continues to increase, and dialysis is offered to older and more medically complex patients. Pain is problematic in up to. Latest news from AFSPA on Federal Employees Health. Atripla 600 mg/200 mg/245 mg film coated tablets - Summary of Product Characteristics (SmPC) by Gilead Sciences Ltd. Information for Health Care Professionals: Cannabis (marihuana, marijuana) and the cannabinoids [Health Canada, 2013]. Hembree and colleagues (2009) formulated practice guidelines for endocrine treatment of transsexual persons. This evidence-based guideline was developed using the. Does adherence to the guideline recommendation for active treatments improve the quality of. Gabapentin in the. Opioid Dosing Guideline for Chronic. PROSPECT Recommendations. A recommendation of anaesthetic choice based on postoperative analgesic effect cannot be made for abdominal hysterectomy, because there is. 8 posts published by Tony Abraham Thomas during April Gabapentin in the treatment of. Opioid Dosing Guideline for Chronic Non-Cancer. While all appear to support the recommendation that COX-2 inhibitors should. Atripla 600 mg/200 mg/ 245 mg film coated tablets - Summary of Product Characteristics (SmPC) by Gilead Sciences Ltd. Can be considered as an alternative to the Mepilex products above or if a patient reports sensitivity issuses following previous use of Mepilex products. 8 posts published by Tony Abraham Thomas during April The prevalence of end-stage renal disease continues to increase, and dialysis is offered to older and more medically complex patients. Pain is problematic. PROSPECT Recommendations. A recommendation of anaesthetic choice based on postoperative analgesic effect cannot be made for abdominal hysterectomy, because there. Hembree and colleagues (2009) formulated practice guidelines for endocrine treatment of transsexual persons. This evidence-based guideline was developed using the Information for Health Care Professionals : Cannabis (marihuana, marijuana) and the cannabinoids [Health Canada, 2013]. Latest news from AFSPA on Federal Employees Health. Marquette General Pharmacy DLP. Renal Dosing Protocol. Drug. Usual Dose. CrCl Adjusted. (ml/min) Dose. Hemodialysis/. Peritoneal Dialysis/ Comments.. Not recommended. Daptomycin (IV). 4-10mg/kg daily. <30.

4 Usual dose q48h. HD Dose as for CrCl. <30ml/min. Give after HD on dialysis days. Enoxaparin (SQ). Advances in Peritoneal Dialysis, Vol. 25, Drug-Induced. Encephalopathy Secondary to Non Renal lowing exposure to usual doses of gabapentin and acyclovir are presented here. Their cases portray the ± 26 ml/min (6). Even the reduced daily dose of. 300 mg gabapentin recommended for ESRD patients. Drug removal by peritoneal dialysis (PD) or continuous renal replacement therapy (CVVHD, CAVHD, etc.) is not equivalent to... permeability. Consult unit pharmacist for dosing adjustment recommendations. Gabapentin (PO)D**. Titrate to clinical response, use caution in renal failure. > mg three times daily. The recommended maintenance dose of NEURONTIN in patients 3 to 4 years of age is. 40 mg/kg/day, hemodialysis is recommended, as follows (see dosing recommendations above for effective doses in each... In a published study, gabapentin (400 mg/kg/day) was administered by intraperitoneal injection to neonatal. An end-stage renal disease patient on long-term peritoneal dialysis was admitted with dizziness, fatigue, hypoglycemia, and hypotension. except gabapentin, the dose of which was recently doubled 1 month before admission. Insulin and C- peptide levels.. Current dose recommendations for gabapentin in patients on. NEUROPATHIC PAIN. Amitriptyline starting dose needs no adjustment unless sedation is undesirable. Must be titrated carefully. If amitriptyline is inappropriate, gabapentin and pregabalin require significant dose adjustments. Dexamethasone does not require dose adjustment, but may be complicated by fluid retention. Contrib Nephrol. 2012;177:30-7. doi: / Epub 2012 May 8. Appropriate drug dosing in patients receiving peritoneal dialysis. Hirata S(1), Kadowaki D. Author information: (1)Division of Clinical Pharmacology, Center for Clinical Pharmaceutical Sciences, Faculty of Pharmaceutical Sciences, Kumamoto. Jul 25, Give supplemental dose of mg after each dialysis. Dosage given should be proportional to maintenance dose. Patients receiving at least 300mg/day can be given the higher supplemental dose of 350mg after each dialysis. Other patients should receive a dosage at the lower end of this range. Feb 1, A study in the USA found up to one-third of haemodialysis patients are prescribed a drug at a dose that differs from the recommended dose and adverse and dialysate (haemodialysis), or by instilling dialysate into the peritoneal cavity and using the peritoneum itself as a membrane (peritoneal dialysis). Atripla 600 mg/200 mg/245 mg film coated tablets - Summary of Product Characteristics (SmPC) by Gilead Sciences Ltd. Information for Health Care Professionals: Cannabis (marihuana, marijuana) and the cannabinoids [Health Canada, 2013]. Latest news from AFSPA on Federal Employees Health. Does adherence to the guideline recommendation for active treatments improve the quality of. Gabapentin in the. Opioid Dosing Guideline for Chronic. Gabapentin in the treatment of. Opioid Dosing Guideline for Chronic Non-Cancer. While all appear to support the recommendation that COX-2 inhibitors should. PROSPECT Recommendations. A recommendation of anaesthetic choice based on postoperative analgesic effect cannot be made for abdominal hysterectomy, because there is. Can be considered as an alternative to the Mepilex products above or if a patient reports sensitivity issuses following previous use of Mepilex products. 8 posts published by Tony Abraham Thomas during April Hembree and colleagues (2009) formulated practice guidelines for endocrine treatment of transsexual persons. This evidence-based guideline was developed using the. The prevalence of end-stage renal disease continues to increase, and dialysis is offered to older and more medically complex patients. Pain is problematic in up to. There are no recent pull requests.

5

Analgesia in patients with impaired renal function Formulary Guidance

Analgesia in patients with impaired renal function Formulary Guidance Analgesia in patients with impaired renal function Formulary Guidance Approved by Trust D&TC: January 2010 Revised March 2017 Contents Paragraph Page 1 Aim 4 2 Introduction 4 3 Assessment of renal function

More information

Bioavailability gabapentin capsules vs. tablets

Bioavailability gabapentin capsules vs. tablets Search Bioavailability gabapentin capsules vs. tablets Gabapentin Tablets 600 mg. Gabapentin bioavailability is not dose morphine capsule was administered 2 hours prior to a 600-mg gabapentin capsule.

More information

PHYSIONEAL Risk Management Plan 2016 MAY 13

PHYSIONEAL Risk Management Plan 2016 MAY 13 VI.2 Elements for a Public Summary VI.2.1 Overview of Disease Epidemiology In Europe, it is estimated that more than 10% of people are affected by kidney disease. The number of patients with end-stage

More information

Neuropathic Pain Treatment Guidelines

Neuropathic Pain Treatment Guidelines Neuropathic Pain Treatment Guidelines Background Pain is an unpleasant sensory and emotional experience that can have a significant impact on a person s quality of life, general health, psychological health,

More information

BACKGROUND Measuring renal function :

BACKGROUND Measuring renal function : A GUIDE TO USE OF COMMON PALLIATIVE CARE DRUGS IN RENAL IMPAIRMENT These guidelines bring together information and recommendations from the Palliative Care formulary (PCF5 ) BACKGROUND Measuring renal

More information

Geriatric Pharmacology. Kwi Bulow, M.D. Clinical Professor of Medicine Director, Academic Geriatric Resource Center

Geriatric Pharmacology. Kwi Bulow, M.D. Clinical Professor of Medicine Director, Academic Geriatric Resource Center Geriatric Pharmacology Kwi Bulow, M.D. Clinical Professor of Medicine Director, Academic Geriatric Resource Center Silver Tsunami 2010: 40 million (13%) 2030: 72 million (20%) Baby Boomers (1946-1964)

More information

Overview of Essentials of Pain Management. Updated 11/2016

Overview of Essentials of Pain Management. Updated 11/2016 0 Overview of Essentials of Pain Management Updated 11/2016 1 Overview of Essentials of Pain Management 1. Assess pain intensity on a 0 10 scale in which 0 = no pain at all and 10 = the worst pain imaginable.

More information

Nucynta IR/ Nucynta ER (tapentadol immediate-release and extendedrelease)

Nucynta IR/ Nucynta ER (tapentadol immediate-release and extendedrelease) Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 Subject: Nucynta Page: 1 of 7 Last Review Date: March 18, 2016 Nucynta Description Nucynta IR/ Nucynta

More information

NEUROPATHIC CANCER PAIN STANDARDS AND GUIDELINES

NEUROPATHIC CANCER PAIN STANDARDS AND GUIDELINES NEUROPATHIC CANCER PAIN STANDARDS AND GUIDELINES GENERAL PRINCIPLES Neuropathic pain may be relieved in the majority of patients by multimodal management A careful history and examination are essential.

More information

Cubicin A Guide to Dosing

Cubicin A Guide to Dosing Cubicin A Guide to Dosing Cubicin (Daptomycin) powder for solution for injection or infusion Indications (see SmPC) 1 : Cubicin is indicated for the treatment of the following infections (see sections

More information

Glucophage XR is contra-indicated during breast-feeding.

Glucophage XR is contra-indicated during breast-feeding. Name GLUCOPHAGE XR 1000 mg Prolonged release tablets Active ingredient Metformin hydrochloride Composition Each Glucophage XR 1000 mg prolonged release tablet contains as active ingredient 1000 mg metformin

More information

Application for Endorsement of CQI (Clinical Audit) Activities for MOPS Credits Allocation

Application for Endorsement of CQI (Clinical Audit) Activities for MOPS Credits Allocation Application for Endorsement of CQI (Clinical Audit) Activities for MOPS Credits Allocation Below is the form you need to fill out. NAME Dianne Vicary Health Hawke s Bay DATE JUNE 2012 TITLE OF ACTIVITY

More information

egfr 34 ml/min egfr 130 ml/min Am J Kidney Dis 2002;39(suppl 1):S17-S31

egfr 34 ml/min egfr 130 ml/min Am J Kidney Dis 2002;39(suppl 1):S17-S31 Update on Renal Therapeutics Caroline Ashley Lead Pharmacist Renal Services UCL Centre for Nephrology, Royal Free Hospital, London Kongress für Arzneimittelinformation January 2011 What are we going to

More information

Pravastatin conversion to atorvastatin

Pravastatin conversion to atorvastatin P ford residence southampton, ny Pravastatin conversion to atorvastatin Pravastatin official prescribing information for healthcare professionals. Includes: indications, dosage, adverse reactions, pharmacology

More information

Pain Management Management in Hepatic Hepatic and and Renal Dysfunction

Pain Management Management in Hepatic Hepatic and and Renal Dysfunction Pain Management in Hepatic and Renal Dysfunction Review the pharmacologic basis for medications used in pain management Identify pain medications which hshould ldbe avoided in patients with hepatic dysfunction

More information

Pain and Chronic Kidney Disease

Pain and Chronic Kidney Disease Pain and Chronic Kidney Disease Frank Brennan Palliative Care Physician Department of Nephrology, St George Hospital Renal Supportive Care Symposium St George Hospital August 21 2015 Epidemiology Effect

More information

HYDROCHLORIDE FOR THE TREATMENT OF SECONDARY HYPERPARATHYROIDISM IN PATIENTS WITH END-STAGE RENAL DISEASE ON MAINTENANCE DIALYSIS THERAPY

HYDROCHLORIDE FOR THE TREATMENT OF SECONDARY HYPERPARATHYROIDISM IN PATIENTS WITH END-STAGE RENAL DISEASE ON MAINTENANCE DIALYSIS THERAPY UK RENAL PHARMACY GROUP SUBMISSION TO THE NATIONAL INSTITUTE FOR CLINICAL EXCELLENCE on CINACALCET HYDROCHLORIDE FOR THE TREATMENT OF SECONDARY HYPERPARATHYROIDISM IN PATIENTS WITH END-STAGE RENAL DISEASE

More information

Disclosures. Management of Chronic, Non- Terminal Pain. Learning Objectives. Outline. Drug Schedules. Applicable State Laws

Disclosures. Management of Chronic, Non- Terminal Pain. Learning Objectives. Outline. Drug Schedules. Applicable State Laws Disclosures Management of Chronic, Non- Terminal Pain No financial disclosures or conflicts of interest to report Michael A. Smith, PharmD, BCPS Clinical Assistant Professor, University of Michigan College

More information

The P&T Committee Lisinopril (Qbrelis )

The P&T Committee Lisinopril (Qbrelis ) Situation Background Assessment The P&T Committee Lisinopril (Qbrelis ) Qbrelis, 1 mg/ml lisinopril oral solution, has recently become an FDA- approved formulation. Current practice at UK Chandler Medical

More information

VALCIVIR Tablets (Valacyclovir hydrochloride)

VALCIVIR Tablets (Valacyclovir hydrochloride) Published on: 10 Jul 2014 VALCIVIR Tablets (Valacyclovir hydrochloride) Composition VALCIVIR-500 Tablets Each film-coated tablet contains: Valacyclovir Hydrochloride equivalent to Valacyclovir.. 500 mg

More information

Medical Cannabis. Danial Schecter, MD, CCFP. Vocational Rehabilitation Association November 7th, Executive Director Cannabinoid Medical Clinic

Medical Cannabis. Danial Schecter, MD, CCFP. Vocational Rehabilitation Association November 7th, Executive Director Cannabinoid Medical Clinic Medical Cannabis Danial Schecter, MD, CCFP Executive Director Cannabinoid Medical Clinic Vocational Rehabilitation Association November 7th, 2014 Conflict of Interest This program has not received financial

More information

Neuropathic Pain. Griffith Research Online. Author. Published. Journal Title. Copyright Statement. Downloaded from. Link to published version

Neuropathic Pain. Griffith Research Online. Author. Published. Journal Title. Copyright Statement. Downloaded from. Link to published version Griffith Research Online https://research-repository.griffith.edu.au Neuropathic Pain Author Hall, Tony Published 2010 Journal Title Australian Journal of Pharmacy Copyright Statement Copyright 2010 Australian

More information

Study No.:MPX Title: Rationale: Phase: IIB Study Period: Study Design: Centres: Indication: Treatment: Objectives:

Study No.:MPX Title: Rationale: Phase: IIB Study Period: Study Design: Centres: Indication: Treatment: Objectives: The study listed may include approved and non-approved uses, formulations or treatment regimens. The results reported in any single study may not reflect the overall results obtained on studies of a product.

More information

Non Malignant Pain: Symptom Management

Non Malignant Pain: Symptom Management Non Malignant Pain: Symptom Management Renal Care Symposium July 2018 Anica Vasic Pain Management Unit St George Hospital Definitions Prevalence Assessment Treatment Medications Newer agents: tapentadol,

More information

Suboxone, Zubsolv, Bunavail (buprenorphine with naloxone sublingual tablets and film), Buprenorphine sublingual tablets

Suboxone, Zubsolv, Bunavail (buprenorphine with naloxone sublingual tablets and film), Buprenorphine sublingual tablets Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.70.32 Subject: Suboxone Drug Class Page: 1 of 7 Last Review Date: June 24, 2016 Suboxone Drug Class Description

More information

M0BCore Safety Profile

M0BCore Safety Profile M0BCore Safety Profile Active substance: Aciclovir Pharmaceutical form(s)/strength: Tablets 200, 400 or 800 mg Dispersible tablets 200, 400 or 800 mg Oral suspensions 200 mg or 400 mg per 5 ml. Freeze

More information

1. Developed: June Revised: November 2017; September 2015; December 2013; January 2012; December 2011; April 2010; August 2006.

1. Developed: June Revised: November 2017; September 2015; December 2013; January 2012; December 2011; April 2010; August 2006. Texas Vendor Drug Program Drug Use Criteria: Gabapentin Publication History 1. Developed: June 2006 2. Revised: November 2017; September 2015; December 2013; January 2012; December 2011; April 2010; August

More information

How to switch from gabapentin to lyrica

How to switch from gabapentin to lyrica How to switch from gabapentin to lyrica Search UKMi Switching between Pregabalin and Gabapentin for 29 Nov 2012 How do you switch between pregabalin and gabapentin for neuropathic pain, and vice versa?.

More information

Diabetes and the Elderly: Medication Considerations When Determining Benefits and Risks

Diabetes and the Elderly: Medication Considerations When Determining Benefits and Risks Diabetes and the Elderly: Medication Considerations When Determining Benefits and Risks Gretchen M. Ray, PharmD, PhC, BCACP, CDE Associate Professor UNM College of Pharmacy September 7 th, 2018 DISCLOSURES

More information

13.2 Part VI.2 Elements for a Public Summary

13.2 Part VI.2 Elements for a Public Summary 13.2 Part VI.2 Elements for a Public Summary 13.2.1 Part VI.2.1 Overview of disease epidemiology Chronic pain of moderate to severe intensity occurs in 19% of adult Europeans, seriously affecting the quality

More information

Antiretroviral Dosing in Renal Impairment

Antiretroviral Dosing in Renal Impairment Protease Inhibitors (PIs) Atazanavir Reyataz hard capsules 300 mg once daily taken with ritonavir 100 mg once daily No dosage adjustment is needed for atazanavir in renal impairment Atazanavir use in haemodialysis

More information

Amantadine Extended-Release. Gocovri, Osmolex ER. Description

Amantadine Extended-Release. Gocovri, Osmolex ER. Description Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.75.21 Subject: Amantadine ER Page: 1 of 5 Last Review Date: June 22, 2018 Amantadine Extended-Release

More information

Regional Renal Training

Regional Renal Training Regional Renal Training Palliative and End of Life Care Dr Clare Kendall North Bristol NHS Trust Advanced Kidney Disease Dialysis/Transplant Conservative Management Deteriorating despite dialysis/failing

More information

Dr. G. Michael (Michael) Allan EDMONTON AB Dr. Christina (Tina) S. Korownyk EDMONTON AB MEDICAL CANNABANOIDS IN PRIMARY CARE

Dr. G. Michael (Michael) Allan EDMONTON AB Dr. Christina (Tina) S. Korownyk EDMONTON AB MEDICAL CANNABANOIDS IN PRIMARY CARE Society of Rural Physicians of Canada 26TH ANNUAL RURAL AND REMOTE MEDICINE COURSE ST. JOHN'S NEWFOUNDLAND AND LABRADOR APRIL 12-14, 2018 262 Dr. G. Michael (Michael) Allan EDMONTON AB Dr. Christina (Tina)

More information

GABAPENTIN BNF Gabapentin is a chemical analogue of γ-aminobutyric acid (GABA) but does not act

GABAPENTIN BNF Gabapentin is a chemical analogue of γ-aminobutyric acid (GABA) but does not act GABAPENTIN BNF 4.8.1 Class: Anti-epileptic. Indications: Adjunctive treatment for partial seizures with or without secondary generalisation; 1,2 neuropathic pain of any cause. 3 12 Pharmacology Gabapentin

More information

PFIZER INC. THERAPEUTIC AREA AND FDA APPROVED INDICATIONS: See United States Package Insert (USPI)

PFIZER INC. THERAPEUTIC AREA AND FDA APPROVED INDICATIONS: See United States Package Insert (USPI) PFIZER INC. These results are supplied for informational purposes only. Prescribing decisions should be made based on the approved package insert. For publications based on this study, see associated bibliography.

More information

Lyrica. Lyrica, Lyrica CR (pregabalin) Description

Lyrica. Lyrica, Lyrica CR (pregabalin) Description Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.75.18 Subject: Page: 1 of 7 Last Review Date: March 16, 2018 Description, CR (pregabalin) Background

More information

The legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION. 9 March 2011

The legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION. 9 March 2011 The legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION 9 March 2011 TAREG 3 mg/ml oral solution B/1 160 ml (CIP code: 491 474-8) Applicant: NOVARTIS PHARMA SAS valsartan

More information

21 st June BDS BASHD Therapeutics Pain and Analgesia. BASHD Therapeutics Analgesics and Pain Management. Links to other BASHD content

21 st June BDS BASHD Therapeutics Pain and Analgesia. BASHD Therapeutics Analgesics and Pain Management. Links to other BASHD content Volume of Prescribing by Dentists 2011 ( a reminder) BASHD Therapeutics Analgesics and Pain Management Analgesics account for 1 in 80 dental prescriptions made A lot more analgesics will be suggested for

More information

SHC Vancomycin Dosing Guide

SHC Vancomycin Dosing Guide SHC Vancomycin Dosing Guide A: Initial dosing considerations B. Pharmacodynamic Targets: goal AUC and troughs C. Loading dose D: Initial Vancomycin Maintenance Dosing and Serum Concentration Monitoring

More information

- SLED Sustained Low-Efficiency Dialysis

- SLED Sustained Low-Efficiency Dialysis Continuous Renal Replacement Therapy Gregory M. Susla, Pharm.D., F.C.C.M. Associate Director, Medical Information MedImmune, LLC Gaithersburg, MD 1 Definition of Terms - SCUF - Slow Continuous Ultrafiltration

More information

IF I M NOT TREATING WITH OPIOIDS, THEN WHAT AM I SUPPOSED TO USE?

IF I M NOT TREATING WITH OPIOIDS, THEN WHAT AM I SUPPOSED TO USE? NON-OPIOID TREATMENT OPTIONS FOR CHRONIC PAIN Alison Knutson, PharmD, BCACP Medication Management Pharmacist Park Nicollet Creekside Clinic Dr. Knutson indicated no potential conflict of interest to this

More information

Have you seen a patient like Elaine *?

Have you seen a patient like Elaine *? (linagliptin) 5mg tablets Have you seen a patient like Elaine *? *Hypothetical patient profile Elaine * : 60 years old Housewife *Hypothetical patient profile ELAINE*: T2D Patient with early signs of kidney

More information

Methadone Maintenance

Methadone Maintenance Methadone Maintenance A Practical Guide to Pharmacotherapy Methadone/Buprenorphine 101 Workshop, April 1, 2017 Ron Joe, MD, DABAM Objectives I. Pharmacology Of Methadone II. Practical Application of Pharmacology

More information

Public Assessment Report. EU worksharing project paediatric data. Valcyte. Valganciclovir

Public Assessment Report. EU worksharing project paediatric data. Valcyte. Valganciclovir Public Assessment Report EU worksharing project paediatric data Valcyte Valganciclovir Currently approved indication(s): Pharmaceutical form(s) affected by this project: Strength(s) affected by this variation:

More information

Practice Name. Audit Undertaken By and Job Title. Date of Audit

Practice Name. Audit Undertaken By and Job Title. Date of Audit Pregabalin Audit Template This template can be used to document the Pregabalin audit undertaken by practices as part of the Incentive Scheme. It has been produced to provide practices with a guide but

More information

Chronic renal failure

Chronic renal failure Chronic renal failure Dr. Alexander Woywodt Consultant Physician and Nephrologist / Hon. Senior Lecturer Lancashire Teaching Hospitals NHS Foundation Trust Fleetwood 23rd June 2009 Menu Epidemiology &

More information

CONTRAINDICATIONS: Hypersensitivity to the active substance or to any of the excipients

CONTRAINDICATIONS: Hypersensitivity to the active substance or to any of the excipients Galvus PRESENTATION: Each tablet contains 50 mg of Vildagliptin INDICATIONS: For the treatment of type 2 diabetes mellitus in adults: i) As monotherapy in patients inadequately controlled by diet and exercise

More information

Volume 9; Number 3 March 2015 PRESCRIBING AND DISPENSING PREGABALIN FOR NEUROPATHIC PAIN

Volume 9; Number 3 March 2015 PRESCRIBING AND DISPENSING PREGABALIN FOR NEUROPATHIC PAIN Arden and Greater East Midlands Commissioning Support Unit in association with Lincolnshire Clinical Commissioning Groups, Lincolnshire Community Health Services, United Lincolnshire Hospitals Trust and

More information

Fighting the Good Fight: How to Convert Opioids Just Right!

Fighting the Good Fight: How to Convert Opioids Just Right! Fighting the Good Fight: How to Convert Opioids Just Right! Tanya J. Uritsky, PharmD, BCPS, CPE Clinical Pharmacy Specialist - Pain Medication Stewardship Hospital of the University of Pennsylvania - Philadelphia,

More information

PART VI: TAPERING OPIOIDS ROBERT JENKINSON MD MARCH 7, 2018

PART VI: TAPERING OPIOIDS ROBERT JENKINSON MD MARCH 7, 2018 PART VI: TAPERING OPIOIDS ROBERT JENKINSON MD MARCH 7, 2018 TAPERING OPIOIDS GETTING STARTED ON OPIOIDS IS EASY BUT GETTING PATIENTS OFF IS HARD WE ARE ARE OBLIGED TO TAPER PATIENTS DOWN AND OFF OPIOIDS

More information

Drug dosing in patients with acute kidney injury

Drug dosing in patients with acute kidney injury Drug dosing in patients with acute kidney injury They don t know what they are doing Jan Jan T. T. Kielstein Department of of Nephrology and and Hypertension Medical School School Hannover Drug dosing

More information

Vancomycin: Class: Antibiotic.

Vancomycin: Class: Antibiotic. Vancomycin: Class: Antibiotic. Indications: Treatment of patients with infections caused by staphylococcal species and streptococcal Species. Available dosage form in the hospital: 1G VIAL, 500MG VIAL.

More information

Knock Out Opioid Abuse in New Jersey:

Knock Out Opioid Abuse in New Jersey: Knock Out Opioid Abuse in New Jersey: A Resource for Safer Prescribing GUIDELINE FOR PRESCRIBING OPIOIDS FOR CHRONIC PAIN IMPROVING PRACTICE THROUGH RECOMMENDATIONS CDC s Guideline for Prescribing Opioids

More information

Have you seen a patient like Carol *?

Have you seen a patient like Carol *? (linagliptin) 5mg tablets Have you seen a patient like Carol *? *Hypothetical patient profile Carol * : 70 years old Retired schoolteacher *Hypothetical patient profile CAROL*: T2D patient with moderate

More information

Lyrica. Lyrica (pregabalin) Description

Lyrica. Lyrica (pregabalin) Description Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.75.18 Subject: Lyrica Page: 1 of 6 Last Review Date: June 22, 2017 Lyrica Description Lyrica (pregabalin)

More information

If Not Opioids then LEAH EDMONDS CSHP OCTOBER 26, 2017

If Not Opioids then LEAH EDMONDS CSHP OCTOBER 26, 2017 If Not Opioids then what LEAH EDMONDS CSHP OCTOBER 26, 2017 Disclosure Nothing to disclose Objectives Identify various non-opioid options for the treatment of chronic non cancer pain Choose appropriate

More information

Reefer Madness version 3.0*

Reefer Madness version 3.0* Reefer Madness version 3.0* Presenter Disclosure *Original Reefer Madness: FMF 2014 by R. Dubin, Sharon Cirone and Mel Kahan Update on Health Canada s MMPR and the use of cannabis for medical conditions

More information

MEDICAL CANNABIS PATIENT COUNSELING. Krissy Bernazani, RPh Clinical Director Zen Leaf

MEDICAL CANNABIS PATIENT COUNSELING. Krissy Bernazani, RPh Clinical Director Zen Leaf MEDICAL CANNABIS PATIENT COUNSELING Krissy Bernazani, RPh Clinical Director Zen Leaf DISCLOSURE Krissy Bernazani is a paid employee of Freestate Wellness, dba Zen Leaf Maryland, a medical cannabis dispensary.

More information

Guidelines for the Management of Chronic Non-Malignant Pain (CNMP) in Primary Care (not including neuropathic pain (NeP).

Guidelines for the Management of Chronic Non-Malignant Pain (CNMP) in Primary Care (not including neuropathic pain (NeP). Surrey (East Surrey CCG, Guildford & Waverley CCG, North West Surrey CCG, Surrey Downs CCG & Surrey Heath CCG) North East Hampshire & Farnham CCG and Crawley, Horsham & Mid-Sussex CCG Guidelines for the

More information

Cetirizine Proposed Core Safety Profile

Cetirizine Proposed Core Safety Profile Cetirizine Proposed Core Safety Profile Posology and method of administration Elderly subjects: data do not suggest that the dose needs to be reduced in elderly subjects provided that the renal function

More information

Media Contacts: Amy Rose Investor Contact: Graeme Bell (908) (908)

Media Contacts: Amy Rose Investor Contact: Graeme Bell (908) (908) News Release FOR IMMEDIATE RELEASE Media Contacts: Amy Rose Investor Contact: Graeme Bell (908) 423-6537 (908) 423-5185 Tracy Ogden (267) 305-0960 FDA Approves Once-Daily JANUVIA, the First and Only DPP-4

More information

NBPDP Drug Utilization Review Process Update

NBPDP Drug Utilization Review Process Update Bulletin # 802 December 1, 2010 NBPDP Drug Utilization Review Process Update The New Brunswick Prescription Drug Program (NBPDP) employs a Drug Utilization Review (DUR) process which identifies, investigates

More information

HOPE. Considerations. Considerations ISING. Safe Opioid Prescribing Guidelines for ACUTE Non-Malignant Pain

HOPE. Considerations. Considerations ISING. Safe Opioid Prescribing Guidelines for ACUTE Non-Malignant Pain Due to the high level of prescription drug use and abuse in Lake County, these guidelines have been developed to standardize prescribing habits and limit risk of unintended harm when prescribing opioid

More information

Non-opioid and adjuvant pain management

Non-opioid and adjuvant pain management Non-opioid and adjuvant pain management ALLISON JORDAN, MD, HMDC MEDICAL DIRECTOR OF PALLIATIVE CARE SERVICES CHRISTIAN AND ALTON MEMORIAL HOSPITALS ASSOCIATE MEDICAL DIRECTOR, BJC HOSPICE ASSISTANT PROFESSOR

More information

Cannabis for Medical Purposes

Cannabis for Medical Purposes College of Physicians and Surgeons of British Columbia Cannabis for Medical Purposes Preamble This document is a standard of the Board of the College of Physicians and Surgeons of British Columbia. College

More information

Diabetes Management at End of Life. FDA Drug Approval News: Cymbalta (duloxetine) Generic Approval. Follow us Online & on Twitter!

Diabetes Management at End of Life. FDA Drug Approval News: Cymbalta (duloxetine) Generic Approval. Follow us Online & on Twitter! ProCare HospiceCare January/February Edition 2014 On-Demand Clinical News Diabetes Management at End of Life Kristin Braschler, Pharm.D., BCPS Health care providers often encounter diabetes and associated

More information

PARACOD Tablets (Paracetamol + Codeine phosphate)

PARACOD Tablets (Paracetamol + Codeine phosphate) Published on: 22 Sep 2014 PARACOD Tablets (Paracetamol + Codeine phosphate) Composition PARACOD Tablets Each effervescent tablet contains: Paracetamol IP...650 mg Codeine Phosphate IP... 30 mg Dosage Form/s

More information

Long Term Care Formulary HCD - 08

Long Term Care Formulary HCD - 08 1 of 5 PREAMBLE Opioids are an important component of the pharmaceutical armamentarium for management of chronic pain. The superiority of analgesic effect of one narcotic over another is not generally

More information

SUMMARY OF ARIZONA OPIOID PRESCRIBING GUIDELINES FOR THE TREATMENT OF CHRONIC NON-TERMINAL PAIN (CNTP)

SUMMARY OF ARIZONA OPIOID PRESCRIBING GUIDELINES FOR THE TREATMENT OF CHRONIC NON-TERMINAL PAIN (CNTP) 9 SUMMARY OF ARIZONA OPIOID PRESCRIBING GUIDELINES FOR THE TREATMENT OF CHRONIC NON-TERMINAL PAIN (CNTP) SUMMARY OF ARIZONA OPIOID PRESCRIBING GUIDELINES FOR THE TREATMENT OF ACUTE PAIN NONOPIOID TREATMENTS

More information

Pain. November 1, 2006 Dr. Jana Pilkey MD, FRCP(C) Internal Medicine, Palliative Medicine

Pain. November 1, 2006 Dr. Jana Pilkey MD, FRCP(C) Internal Medicine, Palliative Medicine Pain November 1, 2006 Dr. Jana Pilkey MD, FRCP(C) Internal Medicine, Palliative Medicine Objectives To be able to define pain To be able to evaluate pain To be able to classify types of pain To learn appropriate

More information

Pregabalin prescription for terminally ill cancer patients receiving specialist palliative care in an acute hospital

Pregabalin prescription for terminally ill cancer patients receiving specialist palliative care in an acute hospital Yajima et al. Journal of Pharmaceutical Health Care and Sciences (2016) 2:29 DOI 10.1186/s40780-016-0063-6 RESEARCH ARTICLE Open Access Pregabalin prescription for terminally ill cancer patients receiving

More information

In clinical studies, gabapentin efficacy was demonstrated over a range of doses from 1800 mg/day to 3600 mg/day (1-3).

In clinical studies, gabapentin efficacy was demonstrated over a range of doses from 1800 mg/day to 3600 mg/day (1-3). Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.75.17 Subject: Gabapentin Page: 1 of 6 Last Review Date: June 22, 2017 Gabapentin Description Gabapentin

More information

Now available. A maintenance dose of SUBOXONE mg once daily is clinically effective for most patients*1. Once-daily dosing in a single tablet

Now available. A maintenance dose of SUBOXONE mg once daily is clinically effective for most patients*1. Once-daily dosing in a single tablet Now available SUBOXONE Once-daily dosing1 12 mg and 16 mg tablets A maintenance dose of SUBOXONE 12-16 mg once daily is clinically effective for most patients*1 Effective maintenance dosing with SUBOXONE

More information

Extraneal peritoneal dialysis solution , version 6 PUBLIC SUMMARY OF THE RISK MANAGEMENT PLAN

Extraneal peritoneal dialysis solution , version 6 PUBLIC SUMMARY OF THE RISK MANAGEMENT PLAN Extraneal peritoneal dialysis solution 8.10.2015, version 6 PUBLIC SUMMARY OF THE RISK MANAGEMENT PLAN Elements for a Public Summary Overview of Disease Epidemiology In Europe, it is estimated that more

More information

Can you drink alcohol while taking gabapentin

Can you drink alcohol while taking gabapentin Can you drink alcohol while taking gabapentin Gogamz Menu Combining Neurontin and alcohol is typically not advised.. Can I Drink Alcohol While Taking Neurontin?. If you decide to drink while taking Neurontin,.

More information

Full details and resource documents available:

Full details and resource documents available: Clinical & Regulatory News by Pharmerica Urinary Tract Infection (UTI) Second Most Common Cause of Hospital Readmission within 30 days UTIs are prevalent and account for up to 22% of infections in LTC,

More information

Appendix D: Drug Tables

Appendix D: Drug Tables Appendix D: Drug Tables A. Short-acting, Orally Administered Opioids Table D-1: Use of Short-acting, Orally Administered Opioids in Adults [198] Additional Maximum APAP dose: 4000 mg/d (2000 mg/d in chronic

More information

for adults engaged with the Family Wellbeing Service Isle of Wight In Community Pharmacy for Isle of Wight Public Health Commissioned Services

for adults engaged with the Family Wellbeing Service Isle of Wight In Community Pharmacy for Isle of Wight Public Health Commissioned Services The supply of Champix (Varenicline) Tablets 500mcg and 1mg by registered community pharmacists for smoking cessation / management of nicotine withdrawal for adults engaged with the Family Wellbeing Service

More information

POLICY NUMBER: POL 153

POLICY NUMBER: POL 153 Chapter: CLAIMS Subject: MEDICAL CANNABIS Effective Date: October 25, 2018 Last Update: October 25, 2018 PURPOSE STATEMENT The purpose of this policy is to explain how the Workers Compensation Board determines

More information

NHS LINCOLNSHIRE in association with UNITED LINCOLNSHIRE HOSPITALS TRUST

NHS LINCOLNSHIRE in association with UNITED LINCOLNSHIRE HOSPITALS TRUST NHS LINCOLNSHIRE in association with UNITED LINCOLNSHIRE HOSPITALS TRUST SHARED CARE GUIDELINE: CINACALCET in the management of secondary hyperparathyroidism in adult patients with end-stage renal disease

More information

(Max 2 g) = to nearest 250 mg

(Max 2 g) = to nearest 250 mg Appendix 1 (part 1 of 8): Rubric for competency assessment of pharmacists prescribing and managing vancomycin Empiric Dosing Phase Pts Yes No Data Error OP Did the pharmacist document the indication 2

More information

5 MUSCULOSKELETAL SYSTEM

5 MUSCULOSKELETAL SYSTEM 5 MUSCULOSKELETAL SYSTEM 5.01 NON-STEROIDAL ANTIILAMMATORY DRUGS (NSAIDS) *Acetylsalicylic Acid (Aspirin) Tab Soluble 300mg Diclofenac Sodium Tab 25mg, Supp 25mg, 50mg & 100mg (Voltaren) 300-900mg every

More information

What strengths do gabapentin come in

What strengths do gabapentin come in Cari untuk: Cari Cari What strengths do gabapentin come in All of the following medications are gluten free unless otherwise noted. Generic drugs can be produced from many manufacturers and not all manufacturers

More information

Diabetes in Renal Patients. Contents. Understanding Diabetic Nephropathy

Diabetes in Renal Patients. Contents. Understanding Diabetic Nephropathy Diabetes in Renal Patients Contents Understanding Diabetic Nephropathy What effect does CKD have on a patient s diabetic control? Diabetic Drugs in CKD and Dialysis Patients Hyper and Hypoglycaemia in

More information

Dr. P. Rushatamukayanunt 18/01/2016

Dr. P. Rushatamukayanunt 18/01/2016 Dr. P. Rushatamukayanunt 18/01/2016 Pain An unpleasant sensory and emotional experience associated with actual or potential tissue damage, and lasts beyond the normal time for healing. What is chronic

More information

Budesonide equivalent dosing

Budesonide equivalent dosing Budesonide equivalent dosing dosage, adverse reactions, pharmacology and more. Budesonide 0.5mg Nebuliser Suspension (Breath Ltd) - Summary of Product Characteristics (SmPC) by Actavis UK Ltd 11-9-2012

More information

GRALISE (gabapentin) oral tablet

GRALISE (gabapentin) oral tablet GRALISE (gabapentin) oral tablet Coverage for services, procedures, medical devices and drugs are dependent upon benefit eligibility as outlined in the member's specific benefit plan. This Pharmacy Coverage

More information

Opana 15 mg street price new formulation

Opana 15 mg street price new formulation Opana 15 mg street price new formulation Search 28-11-2017 Our Word of the Year choice serves as a symbol of each year s most meaningful events and lookup trends. It is an opportunity for us to reflect

More information

Pharmaceutical form(s)/strength: 50, 100, 200, 400 mg tablets P-RMS:

Pharmaceutical form(s)/strength: 50, 100, 200, 400 mg tablets P-RMS: 0BCore Safety Profile Active substance: Amisulpride Pharmaceutical form(s)/strength: 50, 100, 200, 400 mg tablets P-RMS: IE/H/PSUR/0017/002 Date of FAR: 28.11.2012 Core Safety Profile [amisulpride] Formulations:

More information

Scottish Medicines Consortium

Scottish Medicines Consortium Scottish Medicines Consortium pregabalin, 25mg, 50mg, 75mg, 100mg, 150mg, 200mg, 225mg, 300mg capsules (Lyrica ) No. (389/07) Pfizer Limited 6 July 2007 The Scottish Medicines Consortium has completed

More information

Opioid rotation or switching may be considered if a patient obtains pain relief with one opioid and is suffering severe adverse effects.

Opioid rotation or switching may be considered if a patient obtains pain relief with one opioid and is suffering severe adverse effects. Dose equivalence and switching between opioids Key Messages Switching from one opioid to another should only be recommended or supervised by a healthcare practitioner with adequate competence and sufficient

More information

Merck & Co, Inc. Announced Approval of JANUVIA TM (INN: sitagliptin), a new oral treatment of diabetes, by the US FDA

Merck & Co, Inc. Announced Approval of JANUVIA TM (INN: sitagliptin), a new oral treatment of diabetes, by the US FDA October 23, 2006 Ono Pharmaceutical Co., Ltd., Public Relations Phone: +81-6-6263-5670 Banyu Pharmaceutical Co., Ltd., Public Relations Phone: +81-3-6272-1001 Merck & Co, Inc. Announced Approval of JANUVIA

More information

Trust Guideline for the Use of Parenteral Vancomycin and Teicoplanin in Adults

Trust Guideline for the Use of Parenteral Vancomycin and Teicoplanin in Adults A clinical guideline recommended for use: In: By: For: Division responsible for document: Key words: Names of document authors: Job titles of document authors: Name of document author s Line Manager: Job

More information

Pain Management and Safe use of opioids in hospitals. Kyoung-Sil Kang, PharmD, BCPS Scott Tam, PharmD Lauve Casimir, RN, MSN

Pain Management and Safe use of opioids in hospitals. Kyoung-Sil Kang, PharmD, BCPS Scott Tam, PharmD Lauve Casimir, RN, MSN Pain Management and Safe use of opioids in hospitals Kyoung-Sil Kang, PharmD, BCPS Scott Tam, PharmD Lauve Casimir, RN, MSN Bronx Care Health System Bronx Lebanon Hospital Concourse/ Fulton division, Nursing

More information

Amber D. Hartman, PharmD Specialty Practice Pharmacist James Cancer Center & Solove Research Institute Ohio State University Medical Center

Amber D. Hartman, PharmD Specialty Practice Pharmacist James Cancer Center & Solove Research Institute Ohio State University Medical Center Pharmacologic Management of Pain Amber D. Hartman, PharmD Specialty Practice Pharmacist James Cancer Center & Solove Research Institute Ohio State University Medical Center Objectives Identify types of

More information

Use of Cannabinoids in Medical Practice

Use of Cannabinoids in Medical Practice Use of Cannabinoids in Medical Practice Annual Scientific Assembly Family Medicine Review 2016 Murray Opdahl BSPE, MD, CCFP Objectives Briefly present: An overview of available cannabinoids Concerns voiced

More information

CIZOREST Tablets (Amisulpride)

CIZOREST Tablets (Amisulpride) Published on: 2 Dec 2015 CIZOREST Tablets (Amisulpride) Composition CIZOREST 50mg Tablets Each film-coated tablet contains: Amisulpride..50 mg CIZOREST 100mg Tablets Each film-coated tablet contains: Amisulpride..100

More information

Opioid Review and MAT Clinic CDC Guidelines

Opioid Review and MAT Clinic CDC Guidelines 1 Opioid Review and MAT Clinic CDC Guidelines January 10, 2018 Housekeeping Use chat feature to inform everyone who s at your clinic Click chat on Zoom option bar Chat Everyone the names of those who are

More information

Policy on Pharmacological Therapies Practice Guidance Note Reducing Dosing Errors with Opioid Medicines V04

Policy on Pharmacological Therapies Practice Guidance Note Reducing Dosing Errors with Opioid Medicines V04 Policy on Pharmacological Therapies Practice Guidance Note Reducing Dosing Errors with Opioid Medicines V04 Date issued Issue 1 Nov 2018 Planned review Nov 2021 PPT-PGN 18 part of NTW(C)38 Pharmaceutical

More information